ES2196381T3 - Comprimidos chupables para liberacion modificada de principios activos en el tracto gastrointestinal. - Google Patents

Comprimidos chupables para liberacion modificada de principios activos en el tracto gastrointestinal.

Info

Publication number
ES2196381T3
ES2196381T3 ES97950197T ES97950197T ES2196381T3 ES 2196381 T3 ES2196381 T3 ES 2196381T3 ES 97950197 T ES97950197 T ES 97950197T ES 97950197 T ES97950197 T ES 97950197T ES 2196381 T3 ES2196381 T3 ES 2196381T3
Authority
ES
Spain
Prior art keywords
gastrointestinal tract
chupable
tablets
modified release
active principles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97950197T
Other languages
English (en)
Inventor
Karsten Cremer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2196381T3 publication Critical patent/ES2196381T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

SE DESCRIBE UNA TABLETA FARMACEUTICA PARA CHUPARSE CON LIBERACION MODIFICADA DE PRINCIPIOS ACTIVOS EN EL TRACTO GASTROINTESTINAL CON PARTICULAS QUE CONTIENEN LOS PRINCIPIOS ACTIVOS, LAS CUALES TIENEN UN PRIMER RECUBRIMIENTO QUE CONTROLA LA LIBERACION, Y UN SEGUNDO RECUBRIMIENTO EXTERNO CON PROPIEDADES RESISTENTES A LA SALIVA. EL PRIMER RECUBRIMIENTO, QUE CONTROLA LA LIBERACION DE LOS PRINCIPIOS ACTIVOS, PUEDE TENER PROPIEDADES DE RETARDAMIENTO O QUE SON RESISTENTES A LOS JUGOS GASTRICOS.
ES97950197T 1996-11-23 1997-11-17 Comprimidos chupables para liberacion modificada de principios activos en el tracto gastrointestinal. Expired - Lifetime ES2196381T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19648576A DE19648576C2 (de) 1996-11-23 1996-11-23 Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt

Publications (1)

Publication Number Publication Date
ES2196381T3 true ES2196381T3 (es) 2003-12-16

Family

ID=7812582

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97950197T Expired - Lifetime ES2196381T3 (es) 1996-11-23 1997-11-17 Comprimidos chupables para liberacion modificada de principios activos en el tracto gastrointestinal.

Country Status (11)

Country Link
US (1) US6270798B2 (es)
EP (1) EP0941070B1 (es)
JP (1) JP2001527526A (es)
KR (1) KR100429489B1 (es)
AT (1) ATE235232T1 (es)
AU (1) AU725493B2 (es)
CA (1) CA2272442C (es)
DE (2) DE19648576C2 (es)
ES (1) ES2196381T3 (es)
NO (1) NO992477D0 (es)
WO (1) WO1998023262A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19849848A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung
DE19933148A1 (de) * 1999-07-20 2001-01-25 Boehringer Ingelheim Int Ambroxolhaltige Lutschtablette
US20060251722A1 (en) * 2005-05-03 2006-11-09 Novavax, Inc. Multi-component vitamin and mineral supplement for the optimal absorption of components
AR077712A1 (es) 2009-08-05 2011-09-14 Idenix Pharmaceuticals Inc Inhibidores de serina proteasa macrociclica
WO2011056764A1 (en) 2009-11-05 2011-05-12 Ambit Biosciences Corp. Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
MY159958A (en) 2009-12-18 2017-02-15 Idenix Pharmaceuticals Inc 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
EP2557938B1 (en) * 2010-01-15 2020-10-14 Kemin Industries (Zhuhai) Co. Ltd. Protected alpha-amylase
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
WO2011112689A2 (en) 2010-03-11 2011-09-15 Ambit Biosciences Corp. Saltz of an indazolylpyrrolotriazine
US8703943B2 (en) 2010-09-01 2014-04-22 Ambit Biosciences Corporation Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
MX2013002383A (es) 2010-09-01 2013-07-05 Ambit Biosciences Corp Sales bromhidrato de una pirazolilaminoquinazolina.
JP2014500275A (ja) 2010-12-06 2014-01-09 フォリカ,インコーポレイテッド 禿頭症を治療するため、および毛髪の成長を促進するための方法
WO2012080050A1 (en) 2010-12-14 2012-06-21 F. Hoffmann-La Roche Ag Solid forms of a phenoxybenzenesulfonyl compound
JP2014503597A (ja) 2011-01-31 2014-02-13 セルジーン コーポレイション シチジンアナログの医薬組成物及びその使用方法
TW201309690A (zh) 2011-02-10 2013-03-01 Idenix Pharmaceuticals Inc 巨環絲胺酸蛋白酶抑制劑,其醫藥組合物及其於治療hcv感染之用途
US20120252721A1 (en) 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
CN104302640A (zh) 2012-03-16 2015-01-21 埃克希金医药品有限公司 3,5-二氨基吡唑激酶抑制剂
PT2833880T (pt) * 2012-04-02 2017-12-06 Pharma Seeds Create Llc Composição de dosagem oral sólida de ibuprofeno compreendendo um copolímero de ácido metacrílico
NZ631142A (en) 2013-09-18 2016-03-31 Axikin Pharmaceuticals Inc Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
EP3046924A1 (en) 2013-09-20 2016-07-27 IDENIX Pharmaceuticals, Inc. Hepatitis c virus inhibitors
US20150174079A1 (en) * 2013-12-24 2015-06-25 Food for Health International, LLC Lozenges with silver nanoparticles
WO2015134560A1 (en) 2014-03-05 2015-09-11 Idenix Pharmaceuticals, Inc. Solid forms of a flaviviridae virus inhibitor compound and salts thereof
IL291000B2 (en) 2014-03-20 2024-04-01 Capella Therapeutics Inc Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer
CA2943231C (en) 2014-03-20 2023-10-24 Capella Therapeutics, Inc. Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer
MY191736A (en) 2014-12-23 2022-07-13 Axikin Pharmaceuticals Inc 3,5-diaminopyrazole kinase inhibitors

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2565107B1 (fr) * 1984-05-30 1986-09-05 Ucb Laboratoires Nouveau medicament a base de charbon actif et son procede de preparation
DE3678641D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Partikel mit konstanter wirkstofffreisetzung.
US4786508A (en) * 1986-05-30 1988-11-22 Warner-Lambert Company Coated dosage forms
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
JPS63258809A (ja) * 1987-04-16 1988-10-26 Towa Yakuhin Kk 医薬活性成分の放出性にすぐれ、かつ苦味を隠蔽した細粒剤
JP2573969B2 (ja) * 1987-10-21 1997-01-22 帝國製薬株式会社 薬物断続放出性口腔内適用製剤
IT1256651B (it) * 1992-12-11 1995-12-12 Giancarlo Santus Composizione farmaceutica a rilascio controllato in sospensione liquida
EP0524180B1 (en) * 1990-04-11 1995-04-26 The Upjohn Company Taste masking of ibuprofen by fluid bed coating
IT1246383B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
US5460825A (en) * 1990-05-23 1995-10-24 Mcneil-Ppc, Inc. Taste mask coatings for preparing chewable pharmaceutical tablets
AU8219191A (en) * 1990-06-14 1992-01-07 Kalmo Enterprises, Inc. Stable aqueous drug suspensions
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
WO1993024109A1 (en) * 1992-06-04 1993-12-09 Smithkline Beecham Corporation Palatable pharmaceutical compositions
DE4333190C2 (de) * 1993-09-29 1996-05-30 Korsatko Werner Univ Prof Dr E Zerbeißtablette mit verzögerter Wirkstoff-Freisetzung

Also Published As

Publication number Publication date
EP0941070A2 (de) 1999-09-15
US6270798B2 (en) 2001-08-07
NO992477L (no) 1999-05-21
DE19648576A1 (de) 1998-06-04
AU5322598A (en) 1998-06-22
KR100429489B1 (ko) 2004-05-03
AU725493B2 (en) 2000-10-12
US20010001668A1 (en) 2001-05-24
ATE235232T1 (de) 2003-04-15
NO992477D0 (no) 1999-05-21
DE19648576C2 (de) 1999-08-12
WO1998023262A3 (de) 1998-09-11
CA2272442C (en) 2004-05-11
KR20000057205A (ko) 2000-09-15
WO1998023262A2 (de) 1998-06-04
CA2272442A1 (en) 1998-06-04
JP2001527526A (ja) 2001-12-25
DE59709645D1 (de) 2003-04-30
EP0941070B1 (de) 2003-03-26

Similar Documents

Publication Publication Date Title
AU5322598A (en) Lozenge for the modified release of active compounds in the gastrointestinal tract
AU7031500A (en) Therapeutic quinazoline compounds
YU36700A (sh) Oralni farmaceutski oblik za doziranje sa produženim oslobađanjem
FI973452L (fi) Nauhoitettu annosmuoto aktiivisen aineen pidennettyyn jakamiseen
MXPA03003895A (es) Formulaciones de hidrocodona de liberacion controlada.
BR9713237B1 (pt) comprimido de liberaÇço controlada de cloridrato de alfuzosina e composiÇço farmacÊutica compreendendo o mesmo.
NO2011009I1 (no) Naproksen- og esomeprazoltabletter med modifisert frisetting
AU5609998A (en) Tablet for the controlled release of active agents
DK0938316T3 (da) Opioidantagonistholdig galenisk formulering
CA2310585A1 (en) Novel administration form comprising an acid-labile active compound
NZ502445A (en) Control of acidic gut syndrome
MY133883A (en) Gastrointestinal drug delivery system
DE69925133D1 (de) Pyrrolobenzodiazepine
HUP0002744A3 (en) Rapidly releasing and taste-masking pharmaceutical dosage form
GB9025372D0 (en) Pharmaceutical dosage forms
DE69631609D1 (en) Tricyclische erythromycinderivate
IL139512A0 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloaxacin or its pharmaceutically suitable salts or hydrates
SE9201930D0 (sv) Gastric antibacterial treatment
DK0616802T3 (da) Oralt præparat til frigivelse i de nedre fordøjelseskanaler
ATE306910T1 (de) Tablette mit verlängerter wirkstoffabgabe im magen
AU4519399A (en) Anti-inflammatory pharmaceutical formulations
GB9907571D0 (en) Compounds
AU2773597A (en) Pharmaceutical compositions for the sustained release of insoluble active principles
FR2766088B1 (fr) Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire
FI964885L (fi) Hidastetusti mahanportin läpi kulkeutuva vaikuttavien aineiden kantaja vaikuttavien aineiden vapauttamiseksi säädellysti ruoansulatuskanavassa